Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 2005

View Archived Issues

Neuroprotective effects of beta-lactam antibiotics

BMP-7 effective in preclinical models of Parkinson's disease and kidney injury

Teduglutide is a potential anti-mucositis therapeutic for chemotherapy patients

Parthenolide: a novel agent from a natural product with potent antileishmanial activity in vitro

GlobeImmune and MycoLogics enter agreement for antifungal vaccines

Phase II trial investigates alagebrium chloride for erectile dysfunction

DPP-IV inhibitor PSN-9301 enters phase II study

Phase II study evaluates recombinant microplasmin in vitreoretinal disorders

Positive preliminary phase III results for Sativex in severe cancer pain

Addex and Ortho-McNeil collaborate in anxiety, depression, schizophrenia

AN-152 enters clinical development

NIAID begins second phase I study of HIV vaccine

Not approvable letter for Marqibo

ID Biomedical commences development of vaccine against H5N1 influenza strain

Advanced Biotherapy completes pilot study in genital herpes

Adenosine Therapeutics enters collaboration agreement in asthma and diabetes

Vesicare available in U.S.

Roche patent covers adenosine A2A receptor ligands

Fujisawa and Wakunaga jointly report novel cephem antibiotics

Pfizer researchers describe androgen receptor antagonists

Protein tyrosine phosphatase PTP-1B inhibitors under study at Roche

MMP inhibitors for treatment of inflammatory conditions

Update on the antitumor effects of bortezomib in MM and non-Hodgkin's lymphoma

BMAP-28 reported to reduce lethality associated with staphylococcal sepsis in mice

OM-197-MP-AC induces maturation of dendritic cells in vitro

IRAK1 shows promise as a novel target in the treatment of atherosclerosis

R-130823, a p38 MAPK inhibitor, effective in models of rheumatoid arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...